Skip to Content


Proposed Data Collections Submitted for Public Comment and Recommendations

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call the CDC Reports Clearance Officer on (404) 639-7090.

Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques for other forms of information technology. Send comments to Anne O'Connor, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA 30333. Written comments should be received within 60 days of this notice.

Proposed Projects: Pediatric and Adult HIV/AIDS Case Reports—New—National Center for HIV, STD, and TB Prevention (NCHSTP). For many years Pediatric and Adult case reports were included in the OMB clearance for the National Disease Surveillance Program—I. Case Reports, OMB Number 0920-0009. This clearance currently includes the formal surveillance of 19 separate reportable diseases which are ongoing to meet the public demand and scientific interest for accurate, consistent, epidemiologic data. These ongoing diseases include: bacterial meningitis, dengue, hantavirus, HIV/AIDS, Idiopathic CD4+T-lymphocytopenia, Kawasaki syndrome, Legionellosis, lyme disease, malaria, Mycobacterium avium Complex Disease, plague, Reye Syndrome, tick-borne Rickettsial Disease, toxic shock syndrome, toxocariasis, trichinosis, typhoid fever, and viral hepatitis. Case Start Printed Page 1683report forms enable CDC to collect demographic, clinical, and laboratory characteristics of cases of these diseases. This information is used to direct epidemiologic investigations, to identify and monitor trends in reemerging infectious diseases or emerging modes of transmission, to search for possible causes or sources of the diseases, and to develop guidelines for the prevention of treatment.

CDC proposes to separate the two HIV/AIDS case reports from the current clearance in order to have the case reports sent to the appropriate CDC organizational entity. Under the current clearance these forms are managed by the staff within the National Centers for Infectious Diseases (NCID). Separating the packages into two clearances will be more efficient for CDC. These forms are used to report all HIV/AIDS cases for children and adults in all 50 states, Guam, the Pacific Islands, Puerto Rico, and the Virgin Islands. The information collected and the methodology used will remain the same. The data will continue to be used for the purposes described in the previous paragraph. The total annualized burden is 4,373 hours. The total cost to respondents is estimated at $65,595.

RespondentsNumber of respondentsNumber of responses per respondentAverage burden per respondent (in hrs.)
HIV/AIDS Adult Case Report5547310/60
HIV/AIDS Pediatric Case Report55410/60
Start Signature

Dated: January 2, 2001.

Nancy Cheal,

Acting Associate Director for Policy, Planning, and Evaluation, Centers for Disease Control and Prevention (CDC).

End Signature End Preamble

[FR Doc. 01-474 Filed 1-8-01; 8:45 am]